RIBOMIC Inc. 4591Short Interest
Estimated short interest in RIBOMIC Inc. (4591) is 4.30% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, Arrowstreet Capital, Limited Partnership, Nomura International plc.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.65% in total). It also excludes 16 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2019-04-26 |
|---|---|
| Latest disclosure | 2026-11-16 (Nomura International plc, 1.13%) |
| Reporting institutions | 23 firms (2739 reports) |
| Peak estimated short interest | 13.77% (2020-07-09, 8 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- Arrowstreet Capital, Limited Partnership
- Nomura International plc
- JPM Securities Japan Co Ltd.
- GOLDMAN SACHS INTERNATIONAL
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-11 | Barclays Capital Securities Ltd | Position 1,050,900 shares | Ratio 1.84% | ▼0.14% | Holding |
| 2026-09-24 | Arrowstreet Capital, Limited Partnership | Position 755,300 shares | Ratio 1.33% | ▼0.13% | Holding |
| 2026-11-16 | Nomura International plc | Position 649,900 shares | Ratio 1.13% | ▲0.05% | Holding |
| 2024-04-03 | Segregated Portfolio D | Position 324,000 shares | Ratio 0.89% | ▼0.01% | No report for 1+ year |
| 2024-07-04 | ARROWSTREET INTERNATIONAL EQUITY EAFE ALPHA EXTENSION FUND L.P. | Position 293,100 shares | Ratio 0.76% | ▼0.06% | No report for 1+ year |
| 2023-04-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 177,300 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2026-09-02 | JPM Securities Japan Co Ltd. | Position 278,200 shares | Ratio 0.49% | ▼0.11% | Below 0.5% |
| 2021-05-18 | Deutsche Bank Aktiengesellschaft, London | Position 139,200 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2026-03-25 | Morgan Stanley MUFG Securities Co., Ltd. | Position 267,900 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-08-12 | Citigroup Global Markets Limited | Position 275,000 shares | Ratio 0.48% | ▼0.04% | Below 0.5% |
| 2019-11-13 | Credit Suisse Securities (Europe) Limited | Position 76,300 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-10-15 | MERRILL LYNCH INTERNATIONAL | Position 269,930 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2022-10-18 | Credit Suisse AG | Position 124,900 shares | Ratio 0.43% | ▼0.13% | Below 0.5% |
| 2026-01-19 | UBS AG | Position 220,500 shares | Ratio 0.40% | ▼0.14% | Below 0.5% |
| 2022-12-05 | JANE STREET GLOBAL TRADING, LLC | Position 127,300 shares | Ratio 0.35% | ▼0.39% | Below 0.5% |
| 2026-06-04 | Nomura Securities Co., Ltd. | Position 186,299 shares | Ratio 0.33% | ▼0.18% | Below 0.5% |
| 2019-12-04 | Credit Suisse Securities (Japan) Limited | Position 48,500 shares | Ratio 0.30% | ▼0.20% | Below 0.5% |
| 2025-10-29 | GOLDMAN SACHS INTERNATIONAL | Position 149,853 shares | Ratio 0.29% | ▼0.24% | Below 0.5% |
| 2021-12-03 | AIRAIN Ltd. | Position 70,400 shares | Ratio 0.25% | ▼0.25% | Below 0.5% |
| 2022-01-05 | Arrowstreet ACWI ex US Alpha Extension Trust Fund U | Position 71,900 shares | Ratio 0.25% | ▼0.30% | Below 0.5% |
| 2024-07-05 | XTX Markets Pte Ltd | Position 15,900 shares | Ratio 0.04% | ▼0.52% | Below 0.5% |
| 2025-01-27 | SMBC Nikko Securities Inc. | Position 0 shares | Ratio 0.00% | ▼0.78% | Closed |
| 2025-08-12 | Evo Fund | Position 0 shares | Ratio 0.00% | ▼4.48% | Closed |
Disclosure History 2739 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-16 | Nomura International plc | Position 649,900 shares | Ratio 1.13% | ▲0.05% | — |
| 2026-11-13 | Nomura International plc | Position 618,000 shares | Ratio 1.08% | ▼0.03% | — |
| 2026-11-12 | Nomura International plc | Position 636,100 shares | Ratio 1.11% | ▲0.05% | — |
| 2026-11-11 | Barclays Capital Securities Ltd | Position 1,050,900 shares | Ratio 1.84% | ▼0.14% | — |
| 2026-11-10 | Nomura International plc | Position 607,700 shares | Ratio 1.06% | ▼0.10% | — |
| 2026-11-09 | Nomura International plc | Position 665,500 shares | Ratio 1.16% | ▼0.20% | — |
| 2026-11-09 | Barclays Capital Securities Ltd | Position 1,135,500 shares | Ratio 1.98% | ▼0.04% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 1,157,600 shares | Ratio 2.02% | ▲0.24% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 1,016,400 shares | Ratio 1.78% | ▼0.08% | — |
| 2026-11-04 | Nomura International plc | Position 777,900 shares | Ratio 1.36% | ▼0.18% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 1,060,400 shares | Ratio 1.86% | ▲0.09% | — |
| 2026-11-02 | Nomura International plc | Position 877,800 shares | Ratio 1.54% | ▼0.16% | — |
| 2026-10-30 | Nomura International plc | Position 967,700 shares | Ratio 1.70% | ▲0.04% | — |
| 2026-10-28 | Nomura International plc | Position 948,400 shares | Ratio 1.66% | ▼0.08% | — |
| 2026-10-26 | Nomura International plc | Position 989,200 shares | Ratio 1.74% | ▼0.07% | — |
| 2026-10-23 | Nomura International plc | Position 1,028,900 shares | Ratio 1.81% | ▲0.10% | — |
| 2026-10-21 | Barclays Capital Securities Ltd | Position 1,008,000 shares | Ratio 1.77% | ▼0.09% | — |
| 2026-10-20 | Nomura International plc | Position 957,100 shares | Ratio 1.68% | ▼0.36% | — |
| 2026-10-19 | Nomura International plc | Position 1,160,400 shares | Ratio 2.04% | ▼0.08% | — |
| 2026-10-16 | Barclays Capital Securities Ltd | Position 1,059,900 shares | Ratio 1.86% | ▼0.11% | — |
| 2026-10-15 | Nomura International plc | Position 1,210,500 shares | Ratio 2.12% | ▲0.08% | — |
| 2026-10-15 | MERRILL LYNCH INTERNATIONAL | Position 269,930 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2026-10-14 | MERRILL LYNCH INTERNATIONAL | Position 294,230 shares | Ratio 0.52% | ▲0.03% | — |
| 2026-10-13 | Nomura International plc | Position 1,161,500 shares | Ratio 2.04% | ▲0.05% | — |
| 2026-10-13 | MERRILL LYNCH INTERNATIONAL | Position 282,530 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-10-13 | Barclays Capital Securities Ltd | Position 1,119,800 shares | Ratio 1.97% | ▼0.11% | — |
| 2026-10-09 | Nomura International plc | Position 1,136,400 shares | Ratio 1.99% | ▼0.04% | — |
| 2026-10-07 | Nomura International plc | Position 1,154,700 shares | Ratio 2.03% | ▲0.49% | — |
| 2026-10-07 | Barclays Capital Securities Ltd | Position 1,185,500 shares | Ratio 2.08% | ▼0.10% | — |
| 2026-10-06 | MERRILL LYNCH INTERNATIONAL | Position 287,630 shares | Ratio 0.50% | ▲0.03% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| HEALIOS K.K.4593 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| BrightPath Biotherapeutics Co.,Ltd.4594 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MIZUHO MEDY CO.,LTD.4595 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kubota Pharmaceutical Holdings Co.,Ltd.4596 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |